Immatics at the CAR-TCR Summit Europe (Feb 25-27) in London, UK
Immatics will attend the CAR-TCR Summit (Feb 25-27) in London, UK! If you are interested in Immatics' role to deliver safe and effective cancer immunotherapies approach Harpreet Singh (CEO Immatics US):
Monday, February 25
2pm - 4pm
Workshop A: "Discovery of Novel Targets and T-Cell Receptors for Cancer Immunotherapies"
Wednesday, February 27
1.30pm - 2pm
Talk: "Personalized T-Cell Therapies to Target Novel Solid Tumor Antigens"
We’re looking forward to interesting and exciting discussions.
Further information on the CAR-TCR Summit Europe here.